Analysts expect enVVeno Medical Corp to report revenue of 0.00 for Q4 24, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | - | 0.00 | - | - | - | 0.00 | 0.00 | - | - | - | - |
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 494,673.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 453,931.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 474,302.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analysts expect enVVeno Medical Corp to report earnings per share of -10.03 for Q3 25, against a range of -10.94 to -9.12. The most recent reported quarter, Q2 26, came in at -5.37, a 18.8% miss against the -4.52 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -12.25 | -10.88 | -7.70 | -11.55 | - | - | -5.88 | -5.37 | - | - | - | - |
| High Estimate | -11.70 | -10.75 | -10.51 | -8.72 | -9.12 | -8.85 | -7.48 | -4.21 | -3.03 | -2.14 | -1.80 | -1.57 |
| Low Estimate | -12.50 | -12.31 | -12.75 | -10.38 | -10.94 | -9.75 | -8.40 | -4.83 | -3.33 | -2.42 | -2.16 | -1.79 |
| Consensus Estimate | -12.10 | -11.53 | -11.63 | -9.55 | -10.03 | -9.30 | -7.94 | -4.52 | -3.18 | -2.28 | -1.98 | -1.68 |